搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
2 小时
Consumer groups ask FTC to block Novo Holdings-Catalent deal
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...
17 小时
on MSN
Jim Cramer Says Novo Nordisk A/S (NVO) ‘Doesn’t Hold A Candle To Eli Lilly’
We recently published an article titled, Jim Cramer’s Latest Lightning Round: 12 Stocks to Watch. In this article, we are ...
FiercePharma
2 小时
EU drug reviewers back Novo Nordisk’s FDA-rejected hemophilia drug, snub PTC’s ...
After hitting a wall with the FDA last year, Novo Nordisk has picked up backing from European drug reviewers for its novel ...
7 小时
Novo Nordisk's Alhemo Drug Recommended for European Approval as Hemophilia Treatment
Novo Nordisk's Alhemo drug has been recommended for European approval as a treatment for hemophilia, the company said Friday.
14 小时
Why this money manager sees FirstService, Novo Nordisk and Microsoft as good long-term holdings
Paul Harris of Harris Douglas Asset Management says he hasn’t sold a stock since 2020. ‘I don’t feel the need to sell ...
22 小时
on MSN
Consumer, labor groups urge FTC to block Catalent sale to Novo Nordisk - report
Five U.S. consumer groups and two big labor unions are pushing for the Federal Trade Commission to block Novo Nordisk ...
8 小时
Novo Nordisk's Alhemo Recommended for European Approval as Treatment for Haemophilia
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
FiercePharma
4 小时
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the ...
Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...
BioSpace
2 小时
It’s Earnings Season. Here’s What to Watch for Following J&J Beat
This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.
9 分钟
Judge Shuts Down Efforts to Expand Scope of Discovery in Ozempic MDL
Judge Karen Marston held that, despite plaintiffs' arguments to the contrary, marketing discovery is not relevant to the ...
17 小时
on MSN
Weight-loss drugs cut drug and alcohol abuse, according to new study
Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence ...
8 小时
on MSN
Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds
Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈